Trials / Unknown
UnknownNCT03186053
Sodium Creatine Phosphate in Heart Valve Surgery
Cardioprotective Effects of Sodium Creatine Phosphate in Valve Surgery: A Prospective Randomized Controlled Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To explore the effect of intraoperative sodium creatine phosphate on myocardial protection in patients undergoing valve surgery
Detailed description
Objective: To explore the effect of intraoperative sodium creatine phosphate on myocardial protection in patients undergoing valve surgery Methods: 250 patients undergoing valve surgery were randomly divided into experimental group and control group. 5g creatine phosphate was dissolved in 50ml saline solution. After induction of anesthesia, the patients were first given a load dose of 1g, 20min (30ml / h) , And then pumped at a rate of 1 g / h (10 ml / h). The control group was treated with saline in the same manner. The cTnI level was measured at the corresponding time points. Hemodynamic indexes and postoperative complications were recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sodium creatine phosphate | sodium creatine phosphate .Loading dose followed by continuous infusion in operation |
| DRUG | saline | .Loading dose followed by continuous infusion in operation |
Timeline
- Start date
- 2017-06-15
- Primary completion
- 2018-07-01
- Completion
- 2018-12-31
- First posted
- 2017-06-14
- Last updated
- 2018-01-31
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03186053. Inclusion in this directory is not an endorsement.